Oncolytic Adenovirus Harboring Interleukin-24 Improves Chemotherapy for Advanced Prostate Cancer
Conclusion: We reported the synergistic anti-tumor efficacy of ZD55-IL-24 and DTX on prostate cancer. Our results suggest that chemotherapy combined with oncolytic adenovirus mediated gene therapy is a promising strategy for the treatment of advanced prostate cancer.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Li-jun Mao, Meng Ding, Kai Xu, Jun Pan, Haiyuan Yu, Chunhua Yang Tags: Research Paper Source Type: research
More News: Adenoviruses | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Docetaxel | Gene Therapy | Genetics | Men | Prostate Cancer | Study | Taxotere